Alperen Taş | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Dr. Alperen Taş | Cardiology | Best Researcher Award

Ahi Evran University | Turkey

Dr. Alperen Taş is an emerging cardiology researcher whose work centers on acute heart failure, coronary syndromes, inflammatory biomarkers, prognostic scoring systems, and no-reflow phenomena. He focuses on developing and validating clinical biomarkers and risk-prediction models that enhance early diagnosis, guide clinical decisions, and improve mortality prediction in high-risk cardiac patients. His peer-reviewed contributions span key diagnostic tools, including the Scottish Inflammatory Prognostic Score, prognostic nutritional index, QT interval–GRACE score integration, intracoronary ECG, HALP score, Osaka Prognostic Score, and novel biomarkers such as PDGF-BB, chemerin, and derived NLR. His collaborative studies explore infective endocarditis, myocardial infarction, coronary no-reflow, heart failure progression, echocardiographic functional assessment, and medication-related cardiovascular effects. He has shared his findings at national cardiology congresses, advancing scientific dialogue on inflammatory markers and cardiovascular prognostication. With 12 publications, 24 citations, and an h-index of 2, Dr. Alperen Taş demonstrates solid developing research impact, strong collaboration, and a promising trajectory in preventive cardiology and biomarker-based risk stratification.

Profile: Scopus

Featured Publications

Taş, A., Tunca, Ç., Tanık, V. O., & Özlek, B. (2025). The Scottish inflammatory prognostic score: A novel biomarker for predicting in-hospital mortality in acute heart failure with reduced ejection fraction. Heart & Lung, 74, 291–299.

Yael Peled | Heart Transplantation Award | Best Researcher Award

Published on by Global Academic Awards

Prof. Yael Peled | Heart Transplantation Award | Best Researcher Award

Prof. Yael Peled, Sheba Medical Center and Tel Aviv University, Sheba Medical Center and Tel Aviv University

👩‍⚕️ Dr. Yael Peled is a distinguished cardiologist and professor at Tel Aviv University, Israel, renowned for her expertise in heart transplantation and heart failure management. With extensive training and certifications from prestigious institutions worldwide, including Sheba Medical Center and Cedars-Sinai Medical Center, she has excelled in both academia and clinical practice. Dr. Peled’s leadership roles at Sheba Medical Center, along with her contributions to international organizations like the International Society of Heart and Lung Transplantation, highlight her commitment to advancing cardiac care. As a respected educator, researcher, and advocate, she continues to make significant strides in the field of cardiology.

 

Publication Profile

Orcid

Education

 

🎓 Dr. Yael Peled embarked on her academic journey at Tel Aviv University, Israel, where she demonstrated exceptional talent and commitment as an undergraduate student in the Faculty of Life Sciences. Graduating with a B.Sc. degree in Biology with summa cum laude honors in 1996, she earned recognition through the Deans’ excellence scholarship. Dr. Peled’s academic pursuits continued at the esteemed Sackler School of Medicine, Tel Aviv University, where she immersed herself in medical studies from 1996 to 2001. Her dedication culminated in the attainment of her M.D. degree in 2001, marking a significant milestone in her journey toward becoming a highly skilled medical professional. 🩺

 

Research Focus

🔬 Dr. Yael Peled’s research primarily focuses on immunological responses and vaccination strategies in heart transplant recipients, particularly concerning SARS-CoV-2 variants. Through her extensive contributions to journals like The Journal of Heart and Lung Transplantation and Clinical Transplantation, she explores the efficacy of different vaccine formulations, the dynamics of immune response over time, and the implications of donor-recipient characteristics on transplantation outcomes. Dr. Peled’s dedication to understanding these intricacies aims to enhance clinical practices and optimize patient care in the context of heart transplantation and infectious diseases, particularly during the COVID-19 pandemic. 🩺

 

Publication Top Notes

Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients

BNT162b2‐vaccine‐induced neutralization responses are immune correlates of clinical protection against SARS‐CoV‐2 in heart transplant recipients

Neutralization of SARS‐CoV‐2 variants elicited by the combination of vaccination and natural infection in heart transplant recipients

Two negatives make a positive: Maximizing heart procurement in adult congenital heart disease

Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – Implications for the omicron variant: Correspondence

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant